Trial intelligence / Profile preview

Intratracheal furosemide and salbutamol with surfactant in neonatal respiratory distress syndrome

IRCT2014072714215N1Phase 3Completed

Sponsor
Ahvaz Jundishapur University of Medical Sciences
Start
Mar 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of furosemide, salbutamol and bovactant in respiratory distress syndrome (RDS) (3 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Started Mar 2014; status: completed.

02

Drugs

furosemidesalbutamolbovactant
03

Conditions

respiratory distress syndrome (RDS)

Beyond the preview

Go deeper on IRCT2014072714215N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2014072714215N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call